Director

David Weill, M.D.

Director·TransMedics Group, Inc.

About

Dr. David Weill has served on the TransMedics Board since April 2019.

Since 2016 he has been Principal of the Weill Consulting Group, a biomedical consulting group focusing on organ transplantation and lung disease, and has been involved in the transplant and advanced lung disease fields for over 20 years.

He served as Director of the Lung and Heart-Lung Transplant Program at Stanford University Medical Center from 2005 until 2016 and is the former Director of the Stanford Center for Advanced Lung Diseases; he holds a B.A. and M.D. from Tulane University.

Since April 2019
Age 62
Tenure 7 yrs

Also at TransMedics Group, Inc.

WM Waleed H. Hassanein, M.D. Founder, President and Chief Executive Officer; Director JT James R. Tobin Director; Chairperson of the Board EB Edward M. Basile Director; Chairperson of the Nominating and Corporate Governance Committee TG Thomas J. Gunderson Director; Chairperson of the Compensation Committee EJ Edwin M. Kania, Jr. Director SL Stephanie Lovell Director

Roles

Organization Role Dates Details
TransMedics Group, Inc. Director April 2019–present Current role
Stanford University Medical Center Director of the Lung and Heart-Lung Transplant Program 2005-2016 Also former Director of the Stanford Center for Advanced Lung Diseases.

External roles

Organization Role Dates
Weill Consulting Group Principal 2016-present

Related

Company TransMedics Group, Inc. Company hub Person Waleed H. Hassanein, M.D. Founder, President and Chief Executive Officer; Director Person James R. Tobin Director; Chairperson of the Board Person Edward M. Basile Director; Chairperson of the Nominating and Corporate Governance Committee Person Thomas J. Gunderson Director; Chairperson of the Compensation Committee Person Edwin M. Kania, Jr. Director Person Stephanie Lovell Director Person Merilee Raines Director; Chairperson of the Audit Committee Person Gerardo Hernandez Chief Financial Officer and Treasurer Person Giovanni Cecere Chief Commercial Officer Person Nicholas Corcoran Senior Vice President of Supply Chain and Operations Person Matthew Forsyth Senior Vice President, General Counsel and Corporate Secretary Person Tamer Khayal, M.D. Senior Vice President of International (former Chief Commercial Officer)
Source: TransMedics Group, Inc. proxy statement (SEC Schedule 14A)

Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.

See how VectorShift works for your firm

Request Demo